Divis Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/02/2026 ,inter alia, to consider and approve the unaudited financial ....
DIVISLAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Divi's Laboratories has informed the stock exchanges that its Board of Directors will meet on Wednesday, February 11, 2026, to consider and approve the unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2025 (Q3 FY26). This is a routine regulatory disclosure under SEBI Listing Regulations. The company has also confirmed that the trading window for dealing in its securities remains closed from January 1, 2026, until 48 hours after the results are declared — effectively remaining closed until February 13, 2026.
No direct impact on stock price from this filing alone. Investors should watch February 11, 2026, for the actual Q3 FY26 numbers, which could move the stock depending on performance versus expectations.